𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The role of imatinib plasma level testing in gastrointestinal stromal tumor

✍ Scribed by Suzanne George; Jonathan C. Trent

Publisher
Springer
Year
2010
Tongue
English
Weight
224 KB
Volume
67
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Adjuvant and neoadjuvant imatinib therap
Adjuvant and neoadjuvant imatinib therapy: Current role in the management of gastrointestinal stromal tumors
✍ Burton L. Eisenberg; Jonathan C. Trent πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 French βš– 212 KB

## Abstract Although surgery remains the mainstay for the treatment of primary gastrointestinal stromal tumors (GIST), a significant number of patients experience disease recurrence within 5 years of surgery. The emergence of imatinib therapy for the treatment of patients with advanced GIST has off

Imatinib inhibits various types of activ
Imatinib inhibits various types of activating mutant kit found in gastrointestinal stromal tumors
✍ Hui Chen; Koji Isozaki; Kazuo Kinoshita; Akiko Ohashi; Yasuhisa Shinomura; Yuji πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 150 KB

## Abstract Mutations of proto‐oncogene c‐KIT in gastrointestinal stromal tumors (GISTs) are considered to cause a constitutive activation of KIT responsible for their oncogenesis. Imatinib has therapeutic potential for GISTs because of its inhibitory effect on KIT kinase activity. To investigate t